Literature DB >> 10886255

Target antigens for anti-neutrophil cytoplasmic autoantibodies (ANCA) are on the surface of primed and apoptotic but not unstimulated neutrophils.

J J Yang1, R H Tuttle, S L Hogan, J G Taylor, B D Phillips, R J Falk, J C Jennette.   

Abstract

The reaction of ANCA with ANCA antigens on the surface of neutrophils may play a critical role in the pathogenesis of ANCA vasculitis. Therefore, an understanding of the circumstances that result in surface expression of these antigens is important for an understanding of pathogenic mechanisms. In this study we investigated the surface expression of ANCA antigens on quiescent, primed, and apoptotic neutrophils. ANCA antigens and other granule constituents were not detected on the surface of neutrophils in freshly heparinized blood. ANCA antigens were on the surface of neutrophils primed by in vitro incubation for 4 h and 8 h. These cells did not show evidence of apoptosis. After 24 h incubation, about 30% of the neutrophils were apoptotic, and ANCA antigens and other granule constituents were present on the surface of both apoptotic and non-apoptotic cells. Our data indicate that there are no ANCA antigens on the surface of quiescent neutrophils, but that they are on the surface of primed neutrophils before the cells become apoptotic, and remain on the surface of cells after they become apoptotic. Based on these observations, we hypothesize that ANCA can react in vivo with primed but not quiescent neutrophils. Previously published observations indicate that the interaction of ANCA with primed neutrophils results in neutrophil activation, which may be involved in the pathogenesis of ANCA vasculitis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10886255      PMCID: PMC1905660          DOI: 10.1046/j.1365-2249.2000.01228.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

Review 1.  Pathogenesis of the vascular and glomerular damage in ANCA-positive vasculitis.

Authors:  J C Jennette; R J Falk
Journal:  Nephrol Dial Transplant       Date:  1998       Impact factor: 5.992

Review 2.  Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential.

Authors:  C G Kallenberg; E Brouwer; J J Weening; J W Tervaert
Journal:  Kidney Int       Date:  1994-07       Impact factor: 10.612

3.  Membrane surface proteinase 3 expression and intracytoplasmic immunoglobulin on neutrophils from patients with ANCA-associated vasculitides.

Authors:  E Csernok; W H Schmitt; M Ernst; D F Bainton; W L Gross
Journal:  Adv Exp Med Biol       Date:  1993       Impact factor: 2.622

4.  Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo.

Authors:  E Csernok; M Ernst; W Schmitt; D F Bainton; W L Gross
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

Review 5.  Features of apoptotic cells measured by flow cytometry.

Authors:  Z Darzynkiewicz; S Bruno; G Del Bino; W Gorczyca; M A Hotz; P Lassota; F Traganos
Journal:  Cytometry       Date:  1992

6.  Antibodies against granule proteins activate neutrophils in vitro.

Authors:  L A Charles; M L Caldas; R J Falk; R S Terrell; J C Jennette
Journal:  J Leukoc Biol       Date:  1991-12       Impact factor: 4.962

7.  Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells.

Authors:  C O Savage; B E Pottinger; G Gaskin; C D Pusey; J D Pearson
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

8.  Neutrophil apoptosis is associated with a reduction in CD16 (Fc gamma RIII) expression.

Authors:  I Dransfield; A M Buckle; J S Savill; A McDowall; C Haslett; N Hogg
Journal:  J Immunol       Date:  1994-08-01       Impact factor: 5.422

9.  Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa.

Authors:  A J Porges; P B Redecha; W T Kimberly; E Csernok; W L Gross; R P Kimberly
Journal:  J Immunol       Date:  1994-08-01       Impact factor: 5.422

10.  Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): a Fc gamma RII-dependent process.

Authors:  A H Mulder; P Heeringa; E Brouwer; P C Limburg; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1994-11       Impact factor: 4.330

View more
  15 in total

Review 1.  Immunopathological aspects of systemic vasculitis.

Authors:  I M Bajema; E C Hagen; F Ferrario; E de Heer; J A Bruijn
Journal:  Springer Semin Immunopathol       Date:  2001

Review 2.  The multifaceted functions of neutrophils.

Authors:  Tanya N Mayadas; Xavier Cullere; Clifford A Lowell
Journal:  Annu Rev Pathol       Date:  2013-09-16       Impact factor: 23.472

3.  Transcription of proteinase 3 and related myelopoiesis genes in peripheral blood mononuclear cells of patients with active Wegener's granulomatosis.

Authors:  Chris Cheadle; Alan E Berger; Felipe Andrade; Regina James; Kristen Johnson; Tonya Watkins; Jin Kyun Park; Yu-Chi Chen; Eva Ehrlich; Marissa Mullins; Francis Chrest; Kathleen C Barnes; Stuart M Levine
Journal:  Arthritis Rheum       Date:  2010-06

4.  Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus.

Authors:  Roberto Lande; Dipyaman Ganguly; Valeria Facchinetti; Loredana Frasca; Curdin Conrad; Josh Gregorio; Stephan Meller; Georgios Chamilos; Rosalie Sebasigari; Valeria Riccieri; Roland Bassett; Hideki Amuro; Shirou Fukuhara; Tomoki Ito; Yong-Jun Liu; Michel Gilliet
Journal:  Sci Transl Med       Date:  2011-03-09       Impact factor: 17.956

5.  Prolonged infections associated with antineutrophil cytoplasmic antibodies specific to proteinase 3 and myeloperoxidase: diagnostic and therapeutic challenge.

Authors:  Branka Bonaci-Nikolic; Sladjana Andrejevic; Milorad Pavlovic; Zoran Dimcic; Branislava Ivanovic; Milos Nikolic
Journal:  Clin Rheumatol       Date:  2010-03-20       Impact factor: 2.980

6.  The - 564 A/G polymorphism in the promoter region of the proteinase 3 gene associated with Wegener's granulomatosis does not increase the promoter activity.

Authors:  K Pieters; A Pettersson; U Gullberg; T Hellmark
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

7.  Dendritic cells overexpressing Fas-ligand induce pulmonary vasculitis in mice.

Authors:  S Buonocore; V Flamand; N Claessen; P Heeringa; M Goldman; S Florquin
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

Review 8.  Anti-neutrophil cytoplasmic antibody pathogenesis in small-vessel vasculitis: an update.

Authors:  José A Gómez-Puerta; Xavier Bosch
Journal:  Am J Pathol       Date:  2009-10-08       Impact factor: 4.307

9.  Standardised assessment of membrane proteinase 3 expression. Analysis in ANCA-associated vasculitis and controls.

Authors:  André P van Rossum; Minke G Huitema; Coen A Stegeman; Marc Bijl; Karina de Leeuw; Miek A Van Leeuwen; Pieter C Limburg; Cees G M Kallenberg
Journal:  Ann Rheum Dis       Date:  2007-04-19       Impact factor: 19.103

10.  Maintenance of tolerance by regulation of anti-myeloperoxidase B cells.

Authors:  Donna O Bunch; Jonathan S Silver; Melanie C Majure; Pamela Sullivan; David A Alcorta; Hyunsook Chin; Susan L Hogan; Yoshi I Lindstrom; Stephen H Clarke; Ronald J Falk; Patrick H Nachman
Journal:  J Am Soc Nephrol       Date:  2008-07-23       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.